Skip to main content

Sanger Institute Purchases PacBio RS Single-Molecule Sequencer

Premium

The Wellcome Trust Sanger Institute has purchased a PacBio RS single-molecule sequencer as part of an expansion of Pacific Biosciences’ early-access program, the company said this week.

Earlier this year, PacBio named its first 10 early-access customers (IS 2/23/2010), all located in North America, several of who have received their instruments.

The Sanger Institute, which is expected to obtain its instrument before the end of the year, is the first European customer that PacBio has disclosed in the expansion of its early-access program beyond North America.

The company plans to ship instruments to a “limited number” of early-access sites outside of North America and previously said it is interested in having testing sites in Europe and Asia.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.